Yale Therapeutic Radiology
Smilow Cancer Hospital at Yale New Haven
35 Park Street
New Haven, CT 06511
- Yale Therapeutic RadiologySmilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511
Melissa Rasar Young, MD, PhD
Therapeutic Radiology
Telehealth is available
Patient type treated
Adult
Accepting new patients
Yes
Referral required
From patients or physicians
Biography
Melissa Young, MD, PhD, is a therapeutic radiologist who specializes in treating head and neck, breast, and gynecologic cancers with radiation therapy.
“The ability to play an integral role in how a patient’s cancer is treated—and possibly cured—is a rewarding experience,” Dr. Young says. “I value being able to support my patients through the challenges of cancer therapy.”
Dr. Young says she appreciates collaborating with colleagues from different disciplines to create the best treatment plan for patients with complicated cancers. “That extra support helps strengthen my patient care relationships during and after treatment,” she says.
Dr. Young is the director of Yale Medicine’s Head & Neck Radiotherapy program.
Titles
- Associate Professor of Therapeutic Radiology
- Medical Director, Radiation Oncology Center, Smilow Cancer Hospital Care Center in New Haven, Therapeutic Radiology
- Chief, Head and Neck Radiotherapy Program, Therapeutic Radiology
Education & Training
- ResidentYale School of Medicine (2015)
- MDUniversity of Texas Southwestern Medical School (2010)
- PhDUniversity of Texas Southwestern Medical School (2010)
Additional Information
Honors & Recognitions
- Roentgen Resident/Fellow Research Award: (2015)
Publications
- Rybkin A, Young M, Park H. Will adaptive radiation therapy be the new state-of-the-ART in head and neck cancer? Journal Of The National Cancer Institute 2025, djaf283. PMID: 41066140, DOI: 10.1093/jnci/djaf283.
- Lee V, Rybkin A, Oh P, Izreig S, Park H, Morris L, Hayman T, Young M, Pickering C, Mehra S, Lee N, Kang J. The Role of TP53 in Nodal Metastasis: A Molecular Guide for Neck Management in Oral Cavity Cancer. International Journal Of Radiation Oncology • Biology • Physics 2025, 123: s196. DOI: 10.1016/j.ijrobp.2025.07.1284.
- Rybkin A, Lee V, Young M, Eskander A, Burtness B, Park H, Husain Z. Evaluation of a Novel Prognostic System for Surgically Resected Oral Cavity Carcinoma. Head & Neck 2025 PMID: 40862436, DOI: 10.1002/hed.70022.
- Chen X, Tang X, Xie Y, Cuffari B, Tang C, Cao F, Gao X, Meng Z, Noble P, Young M, Turk O, Shirali A, Gera J, Nishimura R, Zhou J, Hansen J. A lupus-derived autoantibody that binds to intracellular RNA activates cGAS-mediated tumor immunity and can deliver RNA into cells. Science Signaling 2025, 18: eadk3320. PMID: 40132052, PMCID: PMC12076517, DOI: 10.1126/scisignal.adk3320.
- Husain Z, Rybkin A, Lee V, Young M, Eskander A, Burtness B, Park H. Evaluation of a Novel Prognostic System for Overall Survival in Surgically Resected Oral Cavity Carcinoma. International Journal Of Radiation Oncology • Biology • Physics 2024, 120: e759-e760. DOI: 10.1016/j.ijrobp.2024.07.1668.
- Choi R, Young M, Cowper S, Leventhal J. LB777 Atypical presentation of Bullous Pemphigoid unmasked by radiation therapy. Journal Of Investigative Dermatology 2021, 141: b16. DOI: 10.1016/j.jid.2021.07.043.
- Hayman TJ, Bhatia AK, Jethwa KR, Young MR, Park HS. Combinations of immunotherapy and radiation therapy in head and neck squamous cell carcinoma: a narrative review. Translational Cancer Research 2021, 10: 2571-2585. PMID: 35116571, PMCID: PMC8798834, DOI: 10.21037/tcr-20-2096.
- Damast S, Tien C, Young M, Altwerger G, Ratner E. GSOR10 Presentation Time: 3:15 PM Single Implant Hybrid Interstitial Brachytherapy for Cervical Cancer during the COVID-19 Pandemic: An Institutional Approach. Brachytherapy 2021, 20: s54. PMCID: PMC8215885, DOI: 10.1016/j.brachy.2021.06.086.
- Tien C, Damast S, Young M, Kaur M, Kim J, Chen Z. PO03 A Novel Design in Peripheral Channels of a Brachytherapy Multichannel Applicator Demonstrates Significant Differences in Dose to Surrounding Volume. Brachytherapy 2021, 20: s56-s57. DOI: 10.1016/j.brachy.2021.06.091.
- Jacobs D, Torabi SJ, Park HS, Rahmati R, Young MR, Mehra S, Judson BL. Revisiting the Radiation Therapy Oncology Group 1221 Hypothesis: Treatment for Stage III/IV HPV‐Negative Oropharyngeal Cancer. Otolaryngology 2020, 164: 1240-1248. PMID: 33198564, DOI: 10.1177/0194599820969613.
- Laird J, Young M, Damast S. Cervical Cancer. 2020 DOI: 10.1891/9780826155146.0028.
- Laird J, Young M, Damast S. Vulvar Cancer. 2020 DOI: 10.1891/9780826155146.0030.
- Jacobs D, Park H, Young M, Olino K, Rahmati R, Mehra S, Burtness B, Judson B. Assessment of Lymph Node Evaluation in Patients with Clinically Node Negative Merkel Cell Carcinoma of the Head and Neck. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1191-1192. DOI: 10.1016/j.ijrobp.2019.11.099.
- Jacobs D, Park H, Young M, Breen C, Rahmati R, Mehra S, Judson B. An Update on Trends and Disparities in Utilization of Total Laryngectomy: a Population-Based Analysis. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1145-1146. DOI: 10.1016/j.ijrobp.2019.11.214.
- Young MR, Decker RH. SBRT for Early Stage Laryngeal Cancer: Progress, But Not Quite Ready for Prime Time. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: 121-123. PMID: 31422805, DOI: 10.1016/j.ijrobp.2019.05.021.
- Kassick M, Gao S, Park H, Kelly J, Young M, Tien C, Damast S. Does Use of Bowel Prep Improve HDR Cervix Implant Dosimetry? International Journal Of Radiation Oncology • Biology • Physics 2019, 105: e324. DOI: 10.1016/j.ijrobp.2019.06.1808.
- Hochreiter A, Kelly J, Young M, Litkouhi B, Black J, Stromberger C, Higgins S, Schwartz P, Damast S. Outcomes of FIGO 2009 stage IB grade 2 or 3 endometrioid endometrial adenocarcinoma treated with adjuvant vaginal brachytherapy following comprehensive surgical staging. Gynecologic Oncology 2019, 154: 287. DOI: 10.1016/j.ygyno.2019.04.674.
- Haines K, Hochreiter A, Young M, Damast S, Litkouhi B. Risks and patterns of paraaortic node metastasis after chemoradiotherapy for pelvic node-positive paraaortic node negative cervical cancer in the era of metabolic imaging. Gynecologic Oncology 2019, 154: 264. DOI: 10.1016/j.ygyno.2019.04.611.
- Benchetrit L, Torabi SJ, Tate JP, Mehra S, Osborn HA, Young MR, Burtness B, Judson BL. Gender disparities in head and neck cancer chemotherapy clinical trials participation and treatment. Oral Oncology 2019, 94: 32-40. PMID: 31178210, DOI: 10.1016/j.oraloncology.2019.05.009.
- Young M, Stahl J, Black J, Litkouhi B, Damast S. Predictors of Pelvic Recurrence in Stage IB Grade 2-3 Endometrioid Endometrial Adenocarcinoma Treated with Post-Operative Vaginal Brachytherapy. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e656-e657. DOI: 10.1016/j.ijrobp.2018.07.1780.
- Chang E, Mougalian S, Adelson K, Young M, Yu J. Association between metastatic free interval and recurrent metastatic breast cancer survival: Findings from the Surveillance, Epidemiology and End Results database. Journal Of Clinical Oncology 2018, 36: e13069-e13069. DOI: 10.1200/jco.2018.36.15_suppl.e13069.
- Stahl JM, Damast S, Bledsoe TJ, An Y, Verma V, Yu JB, Young MR, Lester-Coll NH. Cost-effectiveness of adjuvant intravaginal brachytherapy in high-intermediate risk endometrial carcinoma. Brachytherapy 2017, 17: 399-406. PMID: 29275078, DOI: 10.1016/j.brachy.2017.11.012.
- Leventhal J, Young MR. Radiation Dermatitis: Recognition, Prevention, and Management. Oncology (Williston Park, N.Y.) 2017, 31: 885-7, 894-9. PMID: 29297172.
- Lester-Coll NH, Park HS, Rutter CE, Corso CD, Young MR, Ratner ES, Litkouhi B, Decker RH, Yu JB, Damast S. Who benefits from chemoradiation in stage III–IVA endometrial cancer? An analysis of the National Cancer Data Base. Gynecologic Oncology 2016, 142: 54-61. PMID: 27151429, DOI: 10.1016/j.ygyno.2016.04.544.
- Young M, Yu J. Chapter 45 Intensity Modulated Radiotherapy and Image Guidance. 2016, 413-426. DOI: 10.1016/b978-0-12-800077-9.00045-1.
- Noble PW, Chan G, Young MR, Weisbart RH, Hansen JE. Optimizing a Lupus Autoantibody for Targeted Cancer Therapy. Cancer Research 2015, 75: 2285-2291. PMID: 25832653, DOI: 10.1158/0008-5472.can-14-2278.
- Young MR, Higgins SA, Ratner E, Yu JB, Mani S, Silasi DA, Azodi M, Rutherford T, Schwartz PE, Damast S. Adjuvant Carboplatin, Paclitaxel, and Vaginal Cuff Brachytherapy for Stage III Endometrial Cancer Analysis of Outcomes and Patterns of Recurrence Based on Pathologic Characteristics. International Journal Of Gynecological Cancer 2015, 25: 431-439. PMID: 25621409, PMCID: PMC5603450, DOI: 10.1097/igc.0000000000000376.
- Noble PW, Young MR, Bernatsky S, Weisbart RH, Hansen JE. A nucleolytic lupus autoantibody is toxic to BRCA2-deficient cancer cells. Scientific Reports 2014, 4: 5958. PMID: 25091037, PMCID: PMC5380011, DOI: 10.1038/srep05958.
- Young M, Higgins S, Yuh W, Mayr N. Gynecologic Cancer. Medical Radiology 2013, 185-219. DOI: 10.1007/174_2013_956.
- Young M, Higgins S, Ratner E, Mani S, Evans S, Silasi D, Azodi M, Rutherford T, Schwartz P, Damast S. Adjuvant Carboplatin/Paclitaxel and Vaginal Brachytherapy for Locally Advanced Endometrial Cancer. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s447-s448. DOI: 10.1016/j.ijrobp.2012.07.1186.
- Deng J, Carbajal L, Evaul K, Rasar M, Jamnongjit M, Hammes S. Nongenomic steroid-triggered oocyte maturation: Of mice and frogs. Steroids 2008, 74: 595-601. PMID: 19071151, PMCID: PMC2702721, DOI: 10.1016/j.steroids.2008.11.010.
- Rasar M, DeFranco D, Hammes S. Paxillin Regulates Steroid-triggered Meiotic Resumption in Oocytes by Enhancing an All-or-None Positive Feedback Kinase Loop*. Journal Of Biological Chemistry 2006, 281: 39455-39464. PMID: 17065147, DOI: 10.1074/jbc.m608959200.
- Rasar M, Hammes S. The Physiology of the Xenopus laevis Ovary. Methods In Molecular Biology 2006, 322: 17-30. PMID: 16739713, DOI: 10.1007/978-1-59745-000-3_2.
- Haas D, White S, Lutz L, Rasar M, Hammes S. The modulator of nongenomic actions of the estrogen receptor (MNAR) regulates transcription-independent androgen receptor-mediated signaling: evidence that MNAR participates in G protein-regulated meiosis in Xenopus laevis oocytes. Endocrinology 2005, 19: 2035-46. PMID: 15831520, PMCID: PMC1482432, DOI: 10.1210/me.2004-0531.
- Stebbins‐Boaz B, Fortner K, Frazier J, Piluso S, Pullen S, Rasar M, Reid W, Sinclair K, Winger E. Oocyte maturation in Xenopus laevis is blocked by the hormonal herbicide, 2,4‐dichlorophenoxy acetic acid. Molecular Reproduction And Development 2003, 67: 233-242. PMID: 14694440, DOI: 10.1002/mrd.10396.
Locations
Yale Therapeutic Radiology
Smilow Cancer Hospital at Yale New Haven
35 Park Street
New Haven, CT 06511
- Yale Therapeutic RadiologySmilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511
Biography
Melissa Young, MD, PhD, is a therapeutic radiologist who specializes in treating head and neck, breast, and gynecologic cancers with radiation therapy.
“The ability to play an integral role in how a patient’s cancer is treated—and possibly cured—is a rewarding experience,” Dr. Young says. “I value being able to support my patients through the challenges of cancer therapy.”
Dr. Young says she appreciates collaborating with colleagues from different disciplines to create the best treatment plan for patients with complicated cancers. “That extra support helps strengthen my patient care relationships during and after treatment,” she says.
Dr. Young is the director of Yale Medicine’s Head & Neck Radiotherapy program.
Titles
- Associate Professor of Therapeutic Radiology
- Medical Director, Radiation Oncology Center, Smilow Cancer Hospital Care Center in New Haven, Therapeutic Radiology
- Chief, Head and Neck Radiotherapy Program, Therapeutic Radiology
Education & Training
- ResidentYale School of Medicine (2015)
- MDUniversity of Texas Southwestern Medical School (2010)
- PhDUniversity of Texas Southwestern Medical School (2010)
Additional Information
Honors & Recognitions
- Roentgen Resident/Fellow Research Award: (2015)
Publications
- Rybkin A, Young M, Park H. Will adaptive radiation therapy be the new state-of-the-ART in head and neck cancer? Journal Of The National Cancer Institute 2025, djaf283. PMID: 41066140, DOI: 10.1093/jnci/djaf283.
- Lee V, Rybkin A, Oh P, Izreig S, Park H, Morris L, Hayman T, Young M, Pickering C, Mehra S, Lee N, Kang J. The Role of TP53 in Nodal Metastasis: A Molecular Guide for Neck Management in Oral Cavity Cancer. International Journal Of Radiation Oncology • Biology • Physics 2025, 123: s196. DOI: 10.1016/j.ijrobp.2025.07.1284.
- Rybkin A, Lee V, Young M, Eskander A, Burtness B, Park H, Husain Z. Evaluation of a Novel Prognostic System for Surgically Resected Oral Cavity Carcinoma. Head & Neck 2025 PMID: 40862436, DOI: 10.1002/hed.70022.
- Chen X, Tang X, Xie Y, Cuffari B, Tang C, Cao F, Gao X, Meng Z, Noble P, Young M, Turk O, Shirali A, Gera J, Nishimura R, Zhou J, Hansen J. A lupus-derived autoantibody that binds to intracellular RNA activates cGAS-mediated tumor immunity and can deliver RNA into cells. Science Signaling 2025, 18: eadk3320. PMID: 40132052, PMCID: PMC12076517, DOI: 10.1126/scisignal.adk3320.
- Husain Z, Rybkin A, Lee V, Young M, Eskander A, Burtness B, Park H. Evaluation of a Novel Prognostic System for Overall Survival in Surgically Resected Oral Cavity Carcinoma. International Journal Of Radiation Oncology • Biology • Physics 2024, 120: e759-e760. DOI: 10.1016/j.ijrobp.2024.07.1668.
- Choi R, Young M, Cowper S, Leventhal J. LB777 Atypical presentation of Bullous Pemphigoid unmasked by radiation therapy. Journal Of Investigative Dermatology 2021, 141: b16. DOI: 10.1016/j.jid.2021.07.043.
- Hayman TJ, Bhatia AK, Jethwa KR, Young MR, Park HS. Combinations of immunotherapy and radiation therapy in head and neck squamous cell carcinoma: a narrative review. Translational Cancer Research 2021, 10: 2571-2585. PMID: 35116571, PMCID: PMC8798834, DOI: 10.21037/tcr-20-2096.
- Damast S, Tien C, Young M, Altwerger G, Ratner E. GSOR10 Presentation Time: 3:15 PM Single Implant Hybrid Interstitial Brachytherapy for Cervical Cancer during the COVID-19 Pandemic: An Institutional Approach. Brachytherapy 2021, 20: s54. PMCID: PMC8215885, DOI: 10.1016/j.brachy.2021.06.086.
- Tien C, Damast S, Young M, Kaur M, Kim J, Chen Z. PO03 A Novel Design in Peripheral Channels of a Brachytherapy Multichannel Applicator Demonstrates Significant Differences in Dose to Surrounding Volume. Brachytherapy 2021, 20: s56-s57. DOI: 10.1016/j.brachy.2021.06.091.
- Jacobs D, Torabi SJ, Park HS, Rahmati R, Young MR, Mehra S, Judson BL. Revisiting the Radiation Therapy Oncology Group 1221 Hypothesis: Treatment for Stage III/IV HPV‐Negative Oropharyngeal Cancer. Otolaryngology 2020, 164: 1240-1248. PMID: 33198564, DOI: 10.1177/0194599820969613.
- Laird J, Young M, Damast S. Cervical Cancer. 2020 DOI: 10.1891/9780826155146.0028.
- Laird J, Young M, Damast S. Vulvar Cancer. 2020 DOI: 10.1891/9780826155146.0030.
- Jacobs D, Park H, Young M, Olino K, Rahmati R, Mehra S, Burtness B, Judson B. Assessment of Lymph Node Evaluation in Patients with Clinically Node Negative Merkel Cell Carcinoma of the Head and Neck. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1191-1192. DOI: 10.1016/j.ijrobp.2019.11.099.
- Jacobs D, Park H, Young M, Breen C, Rahmati R, Mehra S, Judson B. An Update on Trends and Disparities in Utilization of Total Laryngectomy: a Population-Based Analysis. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1145-1146. DOI: 10.1016/j.ijrobp.2019.11.214.
- Young MR, Decker RH. SBRT for Early Stage Laryngeal Cancer: Progress, But Not Quite Ready for Prime Time. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: 121-123. PMID: 31422805, DOI: 10.1016/j.ijrobp.2019.05.021.
- Kassick M, Gao S, Park H, Kelly J, Young M, Tien C, Damast S. Does Use of Bowel Prep Improve HDR Cervix Implant Dosimetry? International Journal Of Radiation Oncology • Biology • Physics 2019, 105: e324. DOI: 10.1016/j.ijrobp.2019.06.1808.
- Hochreiter A, Kelly J, Young M, Litkouhi B, Black J, Stromberger C, Higgins S, Schwartz P, Damast S. Outcomes of FIGO 2009 stage IB grade 2 or 3 endometrioid endometrial adenocarcinoma treated with adjuvant vaginal brachytherapy following comprehensive surgical staging. Gynecologic Oncology 2019, 154: 287. DOI: 10.1016/j.ygyno.2019.04.674.
- Haines K, Hochreiter A, Young M, Damast S, Litkouhi B. Risks and patterns of paraaortic node metastasis after chemoradiotherapy for pelvic node-positive paraaortic node negative cervical cancer in the era of metabolic imaging. Gynecologic Oncology 2019, 154: 264. DOI: 10.1016/j.ygyno.2019.04.611.
- Benchetrit L, Torabi SJ, Tate JP, Mehra S, Osborn HA, Young MR, Burtness B, Judson BL. Gender disparities in head and neck cancer chemotherapy clinical trials participation and treatment. Oral Oncology 2019, 94: 32-40. PMID: 31178210, DOI: 10.1016/j.oraloncology.2019.05.009.
- Young M, Stahl J, Black J, Litkouhi B, Damast S. Predictors of Pelvic Recurrence in Stage IB Grade 2-3 Endometrioid Endometrial Adenocarcinoma Treated with Post-Operative Vaginal Brachytherapy. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e656-e657. DOI: 10.1016/j.ijrobp.2018.07.1780.
- Chang E, Mougalian S, Adelson K, Young M, Yu J. Association between metastatic free interval and recurrent metastatic breast cancer survival: Findings from the Surveillance, Epidemiology and End Results database. Journal Of Clinical Oncology 2018, 36: e13069-e13069. DOI: 10.1200/jco.2018.36.15_suppl.e13069.
- Stahl JM, Damast S, Bledsoe TJ, An Y, Verma V, Yu JB, Young MR, Lester-Coll NH. Cost-effectiveness of adjuvant intravaginal brachytherapy in high-intermediate risk endometrial carcinoma. Brachytherapy 2017, 17: 399-406. PMID: 29275078, DOI: 10.1016/j.brachy.2017.11.012.
- Leventhal J, Young MR. Radiation Dermatitis: Recognition, Prevention, and Management. Oncology (Williston Park, N.Y.) 2017, 31: 885-7, 894-9. PMID: 29297172.
- Lester-Coll NH, Park HS, Rutter CE, Corso CD, Young MR, Ratner ES, Litkouhi B, Decker RH, Yu JB, Damast S. Who benefits from chemoradiation in stage III–IVA endometrial cancer? An analysis of the National Cancer Data Base. Gynecologic Oncology 2016, 142: 54-61. PMID: 27151429, DOI: 10.1016/j.ygyno.2016.04.544.
- Young M, Yu J. Chapter 45 Intensity Modulated Radiotherapy and Image Guidance. 2016, 413-426. DOI: 10.1016/b978-0-12-800077-9.00045-1.
- Noble PW, Chan G, Young MR, Weisbart RH, Hansen JE. Optimizing a Lupus Autoantibody for Targeted Cancer Therapy. Cancer Research 2015, 75: 2285-2291. PMID: 25832653, DOI: 10.1158/0008-5472.can-14-2278.
- Young MR, Higgins SA, Ratner E, Yu JB, Mani S, Silasi DA, Azodi M, Rutherford T, Schwartz PE, Damast S. Adjuvant Carboplatin, Paclitaxel, and Vaginal Cuff Brachytherapy for Stage III Endometrial Cancer Analysis of Outcomes and Patterns of Recurrence Based on Pathologic Characteristics. International Journal Of Gynecological Cancer 2015, 25: 431-439. PMID: 25621409, PMCID: PMC5603450, DOI: 10.1097/igc.0000000000000376.
- Noble PW, Young MR, Bernatsky S, Weisbart RH, Hansen JE. A nucleolytic lupus autoantibody is toxic to BRCA2-deficient cancer cells. Scientific Reports 2014, 4: 5958. PMID: 25091037, PMCID: PMC5380011, DOI: 10.1038/srep05958.
- Young M, Higgins S, Yuh W, Mayr N. Gynecologic Cancer. Medical Radiology 2013, 185-219. DOI: 10.1007/174_2013_956.
- Young M, Higgins S, Ratner E, Mani S, Evans S, Silasi D, Azodi M, Rutherford T, Schwartz P, Damast S. Adjuvant Carboplatin/Paclitaxel and Vaginal Brachytherapy for Locally Advanced Endometrial Cancer. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s447-s448. DOI: 10.1016/j.ijrobp.2012.07.1186.
- Deng J, Carbajal L, Evaul K, Rasar M, Jamnongjit M, Hammes S. Nongenomic steroid-triggered oocyte maturation: Of mice and frogs. Steroids 2008, 74: 595-601. PMID: 19071151, PMCID: PMC2702721, DOI: 10.1016/j.steroids.2008.11.010.
- Rasar M, DeFranco D, Hammes S. Paxillin Regulates Steroid-triggered Meiotic Resumption in Oocytes by Enhancing an All-or-None Positive Feedback Kinase Loop*. Journal Of Biological Chemistry 2006, 281: 39455-39464. PMID: 17065147, DOI: 10.1074/jbc.m608959200.
- Rasar M, Hammes S. The Physiology of the Xenopus laevis Ovary. Methods In Molecular Biology 2006, 322: 17-30. PMID: 16739713, DOI: 10.1007/978-1-59745-000-3_2.
- Haas D, White S, Lutz L, Rasar M, Hammes S. The modulator of nongenomic actions of the estrogen receptor (MNAR) regulates transcription-independent androgen receptor-mediated signaling: evidence that MNAR participates in G protein-regulated meiosis in Xenopus laevis oocytes. Endocrinology 2005, 19: 2035-46. PMID: 15831520, PMCID: PMC1482432, DOI: 10.1210/me.2004-0531.
- Stebbins‐Boaz B, Fortner K, Frazier J, Piluso S, Pullen S, Rasar M, Reid W, Sinclair K, Winger E. Oocyte maturation in Xenopus laevis is blocked by the hormonal herbicide, 2,4‐dichlorophenoxy acetic acid. Molecular Reproduction And Development 2003, 67: 233-242. PMID: 14694440, DOI: 10.1002/mrd.10396.
Locations
Yale Therapeutic Radiology
Smilow Cancer Hospital at Yale New Haven
35 Park Street
New Haven, CT 06511
- Yale Therapeutic RadiologySmilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511
Yale Therapeutic Radiology
Smilow Cancer Hospital at Yale New Haven
35 Park Street
New Haven, CT 06511
- Yale Therapeutic RadiologySmilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511